Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.

ABSTRACT: In severe early-onset epilepsy, precise clinical and molecular genetic diagnosis is complex, as many metabolic and electro-physiological processes have been implicated in disease causation. The clinical phenotypes share many features such as complex seizure types and developmental delay. Molecular diagnosis has historically been confined to sequential testing of candidate genes known to be associated with specific sub-phenotypes, but the diagnostic yield of this approach can be low. We conducted whole-genome sequencing (WGS) on six patients with severe early-onset epilepsy who had previously been refractory to molecular diagnosis, and their parents. Four of these patients had a clinical diagnosis of Ohtahara Syndrome (OS) and two patients had severe non-syndromic early-onset epilepsy (NSEO

SUBMITTER: Martin HC 

PROVIDER: S-EPMC4030775 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature